SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant Genetic Test sale cost 4400 AED
SNAP29 Gene Cerebral Dysgenesis Neuropathy Ichthyosis Palmoplantar Keratoderma Syndrome Genetic Test sale cost 4400 AED SNAP29 Gene Cerebral Dysgenesis Neuropathy Ichthyosis Palmoplantar Keratoderma Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
TCF12 Gene Craniosynostosis Type 3 Genetic Test sale cost 4400 AED TCF12 Gene Craniosynostosis Type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

Craniodiaphyseal dysplasia is a rare genetic disorder characterized by the abnormal development of bones in the skull and face, leading to a distinctive facial appearance and potential neurological complications due to pressure on the brain. The SOST gene plays a critical role in bone formation and density, and mutations in this gene have been associated with the autosomal dominant form of craniodiaphyseal dysplasia.

To diagnose this condition accurately and to guide treatment plans, genetic testing of the SOST gene can be performed. DNA Labs UAE offers a specific genetic test for the SOST gene to identify mutations that cause craniodiaphyseal dysplasia. The test is priced at 4400 AED and is a crucial step for families seeking answers to their medical questions, particularly for those with a history of the disorder or presenting with symptoms suggestive of craniodiaphyseal dysplasia.

This genetic test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the SOST gene. The results can provide valuable information for diagnosis, prognosis, and familial planning, offering insights into the likelihood of passing the condition on to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant Genetic Test

Welcome to DNA Labs UAE’s blog on SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant Genetic Test. In this blog, we will provide detailed information about the test, including its components, price, sample condition, report delivery, method, test type, doctor, test department, pre-test information, and test details.

Test Details:

The SOST gene craniodiaphyseal dysplasia is a rare genetic disorder that is inherited in an autosomal dominant manner. This means that an affected individual has a 50% chance of passing the condition on to each of their children.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of craniodiaphyseal dysplasia, NGS testing can be used to identify mutations or variations in the SOST gene, which is responsible for this condition.

NGS genetic testing involves collecting a DNA sample, usually through a blood or saliva sample, and then sequencing the DNA to identify any variations or mutations in the SOST gene. This can help confirm a diagnosis of craniodiaphyseal dysplasia and provide information about the specific genetic changes causing the condition.

Genetic testing can be helpful for individuals with symptoms of craniodiaphyseal dysplasia, as well as their family members who may be at risk of inheriting the condition. It can provide valuable information for medical management, genetic counseling, and family planning decisions.

It is important to consult with a healthcare professional or genetic counselor to discuss the appropriateness and availability of NGS genetic testing for craniodiaphyseal dysplasia. They can guide you through the process, explain the potential benefits and limitations of testing, and help interpret the results.

Test Name: SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for SOST Gene Craniodiaphyseal dysplasia, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SOST Gene Craniodiaphyseal dysplasia, autosomal dominant NGS Genetic DNA Test gene SOST.

Thank you for reading our blog on SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant Genetic Test. If you have any further questions or would like to schedule a test, please contact DNA Labs UAE.

Test Name SOST Gene Craniodiaphyseal dysplasia autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SOST Gene Craniodiaphyseal dysplasia, autosomal dominant NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SOST Gene Craniodiaphyseal dysplasia, autosomal dominant NGS Genetic DNA Test gene SOST
Test Details

SOST gene craniodiaphyseal dysplasia is a rare genetic disorder that is inherited in an autosomal dominant manner. Autosomal dominant means that an affected individual has a 50% chance of passing the condition on to each of their children.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of craniodiaphyseal dysplasia, NGS testing can be used to identify mutations or variations in the SOST gene, which is responsible for this condition.

NGS genetic testing involves collecting a DNA sample, usually through a blood or saliva sample, and then sequencing the DNA to identify any variations or mutations in the SOST gene. This can help confirm a diagnosis of craniodiaphyseal dysplasia and provide information about the specific genetic changes causing the condition.

Genetic testing can be helpful for individuals with symptoms of craniodiaphyseal dysplasia, as well as their family members who may be at risk of inheriting the condition. It can provide valuable information for medical management, genetic counseling, and family planning decisions.

It is important to consult with a healthcare professional or genetic counselor to discuss the appropriateness and availability of NGS genetic testing for craniodiaphyseal dysplasia. They can guide you through the process, explain the potential benefits and limitations of testing, and help interpret the results.

SKU: TEST-4066 Category:

Related products